A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy

Neurology
G M FenichelH Wang

Abstract

A pilot study suggested that oxandrolone, an anabolic steroid, improved strength in boys with Duchenne dystrophy (DD) and indicated the need for a more definitive study. A 6-month, randomized, double-blind, placebo-controlled study of oxandrolone in boys with an established diagnosis of DD, using the change from baseline to 6 months in the average muscle strength score (MMT) as the primary efficacy measure. The mean change from baseline for the oxandrolone group was +0.035 and that for the placebo group was -0.140. Although the oxandrolone group did not get worse and the placebo patients showed some deterioration in strength, the difference was not significant (p = 0.13). The average of the four quantitative muscle tests (QMT) showed a significant improvement in the oxandrolone-treated boys as compared with placebo. No adverse reactions attributable to oxandrolone were recorded. Although oxandrolone did not produce a significant change in the average manual muscle strength score as compared with placebo, the mean change in QMT was significant. Because oxandrolone is safe, accelerates linear growth, and may have some beneficial effect in slowing the progress of weakness, it may be useful before initiating corticosteroid therapy.

Citations

Jul 13, 2002·Muscle & Nerve·Luciano MerliniLucia Morandi
Feb 24, 2011·Journal of Neurology·Giovanni AntoniniAntonio F Radicioni
Mar 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jonathan B Strober
Aug 30, 2003·Neuroscience and Biobehavioral Reviews·Maria W G Nijhuis-van der SandenBarto J Otten
Sep 11, 2002·Neuromuscular Disorders : NMD·Annamaria De LucaDiana Conte Camerino
Aug 26, 2006·Plastic and Reconstructive Surgery·Mustafa AkyurekUNKNOWN Plastic Surgery Educational Foundation DATA Committee
Jun 6, 2008·Journal of Clinical Neuromuscular Disease·Talal M Al-HarbiMark A Tarnopolsky
Sep 3, 2010·Journal of Clinical Neuromuscular Disease·Tommaso IannittiBeniamino Palmieri
Jan 15, 2005·Paediatric Anaesthesia·Warwick A AmesMark W Crawford
Nov 9, 2004·Pediatric Research·James G Tidball, Michelle Wehling-Henricks
May 5, 2010·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Hugh J McMillanUNKNOWN Canadian Paediatric Neuromuscular Group
Sep 28, 2002·Current Opinion in Neurology·Daniel SkukJacques P Tremblay
Dec 17, 2010·Expert Opinion on Investigational Drugs·Jorn Woerdeman, Willem de Ronde
Jul 5, 2015·Archives of Disease in Childhood·Claire L WoodTim Cheetham
Mar 26, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Anna CozzoliAnnamaria De Luca
Mar 20, 2013·BioMed Research International·David FederMaria Helena Catteli Carvalho
Mar 22, 2016·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Martha M Rumore
Jan 30, 2007·Pharmacology & Therapeutics·Gordon S LynchJames G Ryall
Jun 29, 2005·Annals of Neurology·Diana M EscolarUNKNOWN CINRG Group
Sep 26, 2008·Muscle & Nerve·John H J WokkePascal Laforet
Oct 24, 2013·Journal of Veterinary Internal Medicine·K Marioni-HenryG Diane Shelton
Jan 11, 2005·Neuromuscular Disorders : NMD·Caden SouccarAntonio José Lapa
Jun 6, 2006·Neuromuscular Disorders : NMD·Kristin J KrosschellKathryn J Swoboda
Dec 13, 2006·Pediatric Neurology·Nicolas Deconinck, Bernard Dan
May 29, 2015·Journal of Analytical Toxicology·Matthew W LinakisMichael G Spigarelli
Feb 6, 2003·Cytotherapy·F Rivier, E Gussoni
Aug 29, 2006·Biochimica Et Biophysica Acta·Jeffrey R GuyonLouis M Kunkel
Jul 5, 2016·Expert Review of Neurotherapeutics·Josef Finsterer, Sinda Zarrouk-Mahjoub
May 25, 2002·Journal of Child Neurology·Brenda L Y Wong, Caroline Christopher
Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Jul 27, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·O YilmazH Topaloğlu
Nov 3, 2005·American Journal of Physiology. Endocrinology and Metabolism·Prabhakaran BalagopalDavid Hammond
Jun 7, 2013·The Cochrane Database of Systematic Reviews·Rudolf A KleyMatthias Vorgerd
Sep 12, 2019·Arquivos de neuro-psiquiatria·Lineu Cesar WerneckRosana Herminia Scola
Aug 2, 2002·Clinical Orthopaedics and Related Research·W Douglas BiggarPeter N Ray
Jun 11, 2018·Current Urology Reports·Robert CarrasquilloRanjith Ramasamy
Oct 28, 2015·The American Journal of Case Reports·Vittorio Bianchi, Adriana Marbini
Jul 10, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Vittorio E BianchiAntonio Torsello

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.